Last reviewed · How we verify
A Multicenter, Open-Label, Randomized, Parallel Groups Study to Assess the Long-Term Safety Performance of Fexofenadine Compared to Montelukast in Subjects With Asthma
The purpose of this study is to assess the long-term safety performance of fexofenadine compared to montelukast in subjects with asthma
Details
| Lead sponsor | Sanofi |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 1200 |
| Start date | 2002-02 |
| Completion | 2003-11 |
Conditions
- Asthma
Interventions
- Fexofenadine, Comparator = Montelukast
Primary outcomes
- Safety evaluation
Countries
United States